Skip to content
Menu

UBS Maintains Buy on Boston Scientific, Lowers Price Target to $57

Benzinga Newsdesk 3 weeks ago

Analyst RatingsNewsPrice TargetHot

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

UBS analyst Patrick Wood maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $67 to $57.

UBS analyst Patrick Wood maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $67 to $57.

Read at benzinga.com

← All stock news